Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells.

Literature DB >> 28839081

Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells.

Marco Iannetta¹, Giuseppe Ippolito², Emanuele Nicastri².

Abstract

Entities: Chemical Species

Keywords: Zika virus; antiviral agents; azithromycin; central nervous system infections; pregnancy

Mesh：

Substances：
Azithromycin

Year: 2017 PMID： 28839081 PMCID： PMC5571307 DOI： 10.1128/AAC.01152-17

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

5 in total

1. Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye.

Authors: S Jaruratanasirikul; R Hortiwakul; T Tantisarasart; N Phuenpathom; S Tussanasunthornwong
Journal: Antimicrob Agents Chemother Date: 1996-03 Impact factor: 5.191

Review 2. The Race To Find Antivirals for Zika Virus.

Authors: Juan-Carlos Saiz; Miguel A Martín-Acebes
Journal: Antimicrob Agents Chemother Date: 2017-05-24 Impact factor: 5.191

3. Zika virus cell tropism in the developing human brain and inhibition by azithromycin.

Authors: Hanna Retallack; Elizabeth Di Lullo; Carolina Arias; Kristeene A Knopp; Matthew T Laurie; Carmen Sandoval-Espinosa; Walter R Mancia Leon; Robert Krencik; Erik M Ullian; Julien Spatazza; Alex A Pollen; Caleigh Mandel-Brehm; Tomasz J Nowakowski; Arnold R Kriegstein; Joseph L DeRisi
Journal: Proc Natl Acad Sci U S A Date: 2016-11-29 Impact factor: 11.205

4. Safety of macrolides during pregnancy.

Authors: Kueiyu Joshua Lin; Allen A Mitchell; Wai-Ping Yau; Carol Louik; Sonia Hernández-Díaz
Journal: Am J Obstet Gynecol Date: 2012-12-16 Impact factor: 8.661

5. Maternal and transplacental pharmacokinetics of azithromycin.

Authors: Patrick S Ramsey; Megan B Vaules; Gurinder M Vasdev; William W Andrews; Kirk D Ramin
Journal: Am J Obstet Gynecol Date: 2003-03 Impact factor: 8.661

5 in total

13 in total

1. Reply to Iannetta et al., "Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells".

Authors: Juan-Carlos Saiz; Miguel A Martín-Acebes
Journal: Antimicrob Agents Chemother Date: 2017-08-24 Impact factor: 5.191

2. Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses.

Authors: Chunfeng Li; Shulong Zu; Yong-Qiang Deng; Dapei Li; Kislay Parvatiyar; Natalie Quanquin; Jingzhe Shang; Nina Sun; Jiaqi Su; Zhenyang Liu; Min Wang; Saba R Aliyari; Xiao-Feng Li; Aiping Wu; Feng Ma; Yi Shi; Karin Nielsevn-Saines; Jae U Jung; Frank Xiao-Feng Qin; Cheng-Feng Qin; Genhong Cheng
Journal: Antimicrob Agents Chemother Date: 2019-09-16 Impact factor: 5.191

Review 3. Repurposing of antibiotics for clinical management of COVID-19: a narrative review.

Authors: Abdourahamane Yacouba; Ahmed Olowo-Okere; Ismaeel Yunusa
Journal: Ann Clin Microbiol Antimicrob Date: 2021-05-21 Impact factor: 3.944

Review 4. Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity.

Authors: Stephen L Sturley; Tamayanthi Rajakumar; Natalie Hammond; Katsumi Higaki; Zsuzsa Márka; Szabolcs Márka; Andrew B Munkacsi
Journal: J Lipid Res Date: 2020-05-26 Impact factor: 5.922

Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells.

1. Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye.

Review 2. The Race To Find Antivirals for Zika Virus.

3. Zika virus cell tropism in the developing human brain and inhibition by azithromycin.

4. Safety of macrolides during pregnancy.

5. Maternal and transplacental pharmacokinetics of azithromycin.

1. Reply to Iannetta et al., "Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells".

2. Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses.

Review 3. Repurposing of antibiotics for clinical management of COVID-19: a narrative review.

Review 4. Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity.

Review 5. The current understanding and potential therapeutic options to combat COVID-19.

Review 6. The Rationale for Potential Pharmacotherapy of COVID-19.

7. Erythromycin Estolate Inhibits Zika Virus Infection by Blocking Viral Entry as a Viral Inactivator.

8. Pandemic COVID-19: Current status and challenges of antiviral therapies.

Review 9. A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19).

10. ICR suckling mouse model of Zika virus infection for disease modeling and drug validation.